| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.38 | 1e-07 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-07 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-07 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |